Monoamine oxidase inhibition byl-deprenyl depends on both sex and route of administration in the rat
- 1 December 1993
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 18 (12) , 1299-1304
- https://doi.org/10.1007/bf00975051
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonismJournal of Neuroscience Research, 1991
- A review of the pharmacology of selegilineActa Neurologica Scandinavica, 1991
- Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's diseaseNeurology, 1991
- Histochemical localisation of monoamine oxidase A and B in rat brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- On the substrate specificities of the two forms of monoamine oxidaseJournal of Pharmacy and Pharmacology, 1984
- Metabolism of (‐) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefitNeurology, 1982
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968